Novo Nordisk’s once-daily hemophilia drug Alhemo is approvednews2024-12-23T12:52:19+00:00December 23rd, 2024|Endpoints News|
Vertex gets ‘vanza triple’ approval and Trikafta expansionnews2024-12-23T02:56:01+00:00December 23rd, 2024|Endpoints News|
PBM changes unlikely to join spending bill as shutdown loomsnews2024-12-20T20:17:15+00:00December 20th, 2024|Endpoints News|
Accelerated approval brings Pfizer’s BRAF inhibitor to first-line patientsnews2024-12-20T20:05:59+00:00December 20th, 2024|Endpoints News|
Rhythm receives expanded approval for genetic obesity drugnews2024-12-20T19:17:04+00:00December 20th, 2024|Endpoints News|
Xcovery nabs first FDA approval for lung cancer drugnews2024-12-19T20:19:55+00:00December 19th, 2024|Endpoints News|
Mesoblast wins long-awaited approval for cell therapynews2024-12-19T20:17:15+00:00December 19th, 2024|Endpoints News|
Payers generally meet drug price watchdog’s ‘fair access’ standards, report saysnews2024-12-19T18:28:30+00:00December 19th, 2024|Endpoints News|
Regeneron forges ahead in factor XI despite field’s mixed resultsnews2024-12-19T18:27:20+00:00December 19th, 2024|Endpoints News|
In blow to compounders, FDA reaffirms tirzepatide shortage is overnews2024-12-19T15:36:52+00:00December 19th, 2024|Endpoints News|
